EUVIMEDEUVIMED entdecken
Crossref

Bead bed microfluidic device for testing mechanical embolization of shear-thinning hydrogels

Keuna Jeon, Uijin Kim, Savannah Azzi, Edwin Sanchez Ochoa, Vivek Rajasenan, Xiling Shen, Menekse Ermis, Dino Di Carlo, Ali Khademhosseini, Natashya Falcone

Acta Biomaterialia · 2026-04 · 214 · 198-209

DOI: 10.1016/j.actbio.2026.03.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-04. Verfasst von Keuna Jeon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA. Hauptthemen laut MEDLINE: Hydrogels, Microspheres, Lab-On-A-Chip Devices, Embolization, Therapeutic. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, National Institutes of Health, Terasaki Institute for Biomedical Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths worldwide, despite advancements in therapeutic strategies such as chemotherapeutics, immunotherapy, and transarterial chemoembolization (TACE). The development of embolic agents with enhanced delivery precision and therapeutic efficacy, particularly shear-thinning biomaterials (STBs), has opened new avenues for localized, sustained, and combination cancer therapies. However, current in vitro and ex vivo models for embolic agent testing are limited in their ability to recapitulate the intricate architecture and dynamic microenvironment of human capillary networks. Here, we present a proof-of-concept bead bed microfluidic device designed to emulate physiologically relevant vascular complexity for evaluating mechanical embolic agent performance. This system utilizes photocrosslinkable gelatin methacryloyl (GelMA) microbeads as modular structural elements, where interstitial voids between packed beads mimic capillary-scale networks, and annealed GelMA layers form interconnected pathways representing larger vessels. This platform allows assessment of embolization efficiency, flow behavior, and cell-targeting efficacy of shear-thinning hydrogels and other embolic materials under biologically relevant conditions. By integrating cellular encapsulation within GelMA microbeads, the device enables simultaneous evaluation of embolization and cytotoxic responses, bridging the gap between conventional mechanical flow models and biologically functional assays. This bead bed microfluidic approach provides a versatile and scalable in vitro testing tool aligned with the FDA's initiative toward non-animal testing methodologies, offering a promising route for preclinical screening and optimization of next-generation embolic agents. STATEMENT OF SIGNIFICANCE: This work introduces the first bead-bed microfluidic platform capable of simultaneously evaluating embolization mechanics, drug diffusion, and biological response within a capillary-mimetic 3D matrix. Existing in vitro embolization models rely on simplified bulk gels or rigid channels that fail to reproduce the microscale vascular complexity and dynamic transport conditions governing embolic agent performance. Our system overcomes these limitations by integrating tunable GelMA (gelatin methacryloyl) microbeads, physiologically relevant pore networks, multi-scale channels, and embedded tumor cells to capture both mechanical occlusion and therapeutic delivery behavior. This platform advances non-animal testing approaches and provides a quantitative, biologically functional method for screening next-generation shear-thinning embolic materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsMicrospheresLab-On-A-Chip DevicesEmbolization, TherapeuticShear StrengthHumansGelatinAnimalsMethacrylates

Stichwörter der Autor:innen

Bead-bed microfluidicsEmbolic biomaterialsEmbolization testing deviceGelma beads

Substanzen

HydrogelsGelatingelatin methacryloylMethacrylates

Autor:innen und Institutionen

  • Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA.
  • Department of Bioengineering, University of California, Los Angeles, CA 90095, USA.
  • Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA. Electronic address: khademh@gmail.com.
  • Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA. Electronic address: nfalcone@terasaki.org.

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • National Institutes of Health
  • Terasaki Institute for Biomedical Innovation
  • Foundation for the National Institutes of Health

Zitieren

APA

Jeon, K., Kim, U., Azzi, S., Ochoa, E. S., Rajasenan, V., Shen, X., Ermis, M., Carlo, D. D., Khademhosseini, A., & Falcone, N. (2026). Bead bed microfluidic device for testing mechanical embolization of shear-thinning hydrogels. Acta Biomaterialia, 214, 198-209. https://doi.org/10.1016/j.actbio.2026.03.009

Vancouver

Jeon K, Kim U, Azzi S, Ochoa ES, Rajasenan V, Shen X, et al. Bead bed microfluidic device for testing mechanical embolization of shear-thinning hydrogels. Acta Biomaterialia. 2026;214:198-209. doi:10.1016/j.actbio.2026.03.009

BibTeX
@article{Jeon2026,
  author = {Jeon, Keuna and Kim, Uijin and Azzi, Savannah and Ochoa, Edwin Sanchez and Rajasenan, Vivek and Shen, Xiling and Ermis, Menekse and Carlo, Dino Di and Khademhosseini, Ali and Falcone, Natashya},
  title = {Bead bed microfluidic device for testing mechanical embolization of shear-thinning hydrogels},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {214},
  pages = {198--209},
  doi = {10.1016/j.actbio.2026.03.009}
}
Kostenlos starten →